Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New data disclosed on first PI3Kalpha-specific anticancer agent to enter clinic

April 26, 2012

New Presidio product shows promise to treat hepatitis

April 25, 2012

Phase I data encourage advancement of candidate MS drug to phase II

April 25, 2012

BAF-312 dose titration reduces bradyarrhythmic events in phase II trial

April 25, 2012

New Roche oncolytic targets chondroitin sulfate proteoglycan 4

April 25, 2012

Enanta presents novel antiviral with excellent cross-resistance profile

April 25, 2012

Optimized human protein inhibits thrombosis and neointima formation in vein grafts

April 24, 2012

Discovery of clinical-stage c-Met inhibitor described

April 24, 2012

New HCV NS5B conformational modulator set for clinical testing

April 24, 2012

First phase II data presented on BMS-791325 in hepatitis C

April 24, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...